Facense

Company profile

Facense company profile

Facense Ltd develops lightweight smartglasses with tiny sensors that continuously and unobtrusively measure all vital signs. Facense Corona Smartglasses to detect COVID-19 symptoms early (fever, coughing, shortness of breath) and Facense Corona Control Room are in development. The company plans to add software updates to detect and predict various medical conditions including hypertension, stroke, congestive heart failure, asthma, chronic obstructive pulmonary disease, and migraine. Facense's patent portfolio includes more than 30 US patents and dozens of patent applications around the world on smartglasses with sensors for wellness, telehealth, safety, and industrial applications.